IntroductIon Restoring sinus rhythm in patients with atrial fibrillation (AF)/atrial flutter (AFl) requires adequate oral anticoagulation prior to direct current cardioversion (DCC). Some patients eligible for DCC are not properly anticoagulated.
the use of new oral anticoagulants (NOACs; dabi gatran, rivaroxaban, apixaban, and edoxaban), to be taken for 3 weeks prior to cardioversion, just as in the case of vitamin K antagonists (VKAs).
In clinical practice, a significant number of pa tients admitted to undergo DCC are not prop erly treated with oral anticoagulants (OACs).
3,4

Scheduled patients have a nontherapeutic level of
IntroductIon Restoration of sinus rhythm in patients with atrial fibrillation (AF) or atrial flut ter (AFl) requires proper anticoagulation prior to direct current cardioversion (DCC) due to the in creased risk of thromboembolic complications, in cluding stroke.
1,2 The European Society of Cardiol ogy guidelines concerning the preparation of pa tients with nonvalvular AF for DCC recommend orIGInAL ArtIcLE Safety of transesophageal echocardiography guided electrical cardioversion in patients with atrial fibrillation and inadequate anticoagulation was postponed for a minimum of 3 weeks. All patients gave their written informed consent to undergo both TEE and DCC under a short gen eral anesthesia.
The study exclusion criteria were as follows: age <18 years, valvular heart disease, contrain dications to undergo DCC (eg, LAA thrombus, stroke, pulmonary edema) or TEE (eg, esopha geal disease), contraindications to anticoagulation, and the lack of the patient's informed consent.
Prior to DCC, every patient was administered unfractionated or low molecular weight hepa rin at therapeutic doses. Cardioversion was per formed with biphasic defibrillator under a short general anesthesia (fentanyl/propofol).
The effectiveness of DCC was determined on the basis of sinus rhythm restoration immedi ately after cardioversion and on the day of hos pital discharge. The safety of DCC was assessed on the basis of the following endpoints: stroke, transient ischemic attack (TIA), symptomatic sys temic embolic event, and death. The study was positively assessed by the Bioethics Committee of the Poznan University of Medical Sciences, Poznań, Poland.
Echocardiographic examination TTE and TEE were performed using a Vivid 9 device (General Electric Healthcare, General Electric Healthcare, Horten, Norway). In TTE, we evaluated the basic dimen sions of the left ventricle (LV, in diastole) and LA (in systole), aortic dimensions, blood flow through the valves, and LV ejection fraction (LVEF). A TEE multiplane transducer was used. The study evalu ated the presence of a thrombus in the LAA and SEC in both LA and LAA. Blood clots were iden tified as a circular or irregular mass inside or in the lumen of the LA, not being a part of the en docardium or pectinate muscles. SEC was de fined as a smoke like echo with a characteristic motion during the cardiac cycle.
14 -16 The pres ence of a thrombus in the LA/LAA was a contra indication to DCC, while in the case of the SEC, the decision was made after consultation with other cardiologists.
statistical analysis A statistical analysis was per formed using STATISTICA ver. 12 (StatSoft Inc., 1984-2014, Tulsa, Oklahoma, United States). Qualitative variables were presented as percent age, and quantitative ones-as the arithmetic mean and standard deviation (SD) for normal distribution and median for nonnormal distribu tion. The Mann-Whitney test was used to com pare the 2 groups in a nominal scale and an in terval scale in the absence of normality. More than 2 groups were compared using the KruskalWallis test with the post hoc Dunn test. The χ 2 test of independence was used for the nominal scale. To evaluate the risk of LAA thrombus and SEC, the logistic regression model was used in a univariate analysis and a stepwise backward regression model in a multivariate analysis. To determine the relationship between the mode international normalized ratio (INR) when using VKA before hospitalization or they do not take 1 or more doses of NOACs. The second group con sists of patients admitted urgently due to hemo dynamic deterioration: with heart failure (HF), acute coronary syndrome (ACS), or poor toler ance of arrhythmia. In these cases, it is often difficult to determine the exact duration of ar rhythmia as these patients do not use antico agulation or the efficacy of the treatment is un certain. This group of patients also has the high est risk of thrombus in the left atrial appendage (LAA). 5, 6 In such situations, when it is necessary to treat the patient with DCC, it is recommend ed to perform transesophageal echocardiography (TEE). 7 It has been documented that a reduction in the duration of OAC treatment by performing TEE and, in the absence of contraindications, DCC on the same day may improve the clinical status and well being of the patients, as well as reduce the duration of hospital stay and the number of complications. [8] [9] [10] [11] There have been few studies assessing the val ue of TEE in patients with inadequate or irreg ular anticoagulation. Moreover, there are scarce data on patients admitted urgently due to hemo dynamic deterioration resulting from poorly tol erated AF. 12,13 DCC performed to achieve hemo dynamic stability without prior TEE may lead to thromboembolic complications.
The aim of this study was to evaluate the risk factors for spontaneous echo contrast (SEC) in the left atrium (LA) and the presence of throm bus in the LAA on TEE in patients with AF or AFl. We included patients who were admitted to the hospital to undergo DCC and who had an in adequate anticoagulation prior to hospitaliza tion. In addition, the safety of DCC in elective ly and urgently admitted patients was evaluated.
PAtIEnts And mEthods
This was a retro spective study involving patients with persis tent AF/AFl who underwent TEE prior to DCC. The inclusion criteria were the absence or inad equacy of anticoagulation in the 3 weeks prior to cardioversion (omission of 1 or more doses of NOACs or a documented INR of less than 2 during the 3 to 4 weeks preceding the scheduled DCC). The study included patients admitted for elective DCC as well as for urgent reasons such as poorly tolerated symptoms of arrhythmia (palpi tations, fainting, weakness), ACS, or HF exacer bation. ACS was diagnosed on the basis of clin ical evaluation, electrocardiography, and cardi ac troponin levels. The diagnosis of HF exacer bation was based on previous medical history, clinical presentation, laboratory results (N ter minal pro Btype natriuretic peptide levels), and transthoracic echocardiography (TTE). In all pa tients, the risk of thromboembolic complications was estimated with the CHA 2 DS 2 VASc score on admission to the hospital.
7 TEE was performed in the fasting state on the same day as DCC. In the case of a suspected or evident thrombus, DCC DCC were admitted to the Department of Car diology at the Poznan University of Medical Sci ences. A total of 139 patients (46 women and 93 men) met the inclusion criteria; the mean (SD) age was 63.4 (11.5) years. Forty eight patients were admitted electively, and 91 patients-ur gently. The reasons for performing urgent car dioversion were poor tolerance of arrhythmia (57 patients), ACS (13 patients), and exacerbation of HF (21 patients). On admission, 83 patients (60%) were taking VKAs, 15 patients (11%) were administered NOACs, and 41 patients (29%) did not take any OACs. Aspirin (75 mg/d) was ad ministered in 45 patients (32%), and 20 patients (14%) were on dual antiplatelet therapy (aspirin and clopidogrel, both at a dose of 75 mg/d). Four patients were on triple antithrombotic treatment (VKA, aspirin, and clopidogrel).
TEE revealed an LAA thrombus in 16 patients (11.5%) and LA SEC in 63 patients (45.3%). In 15 patients (94%), the thrombus was accompanied by SEC. Six patients with LAA thrombus were on treatment with dual antithrombotic therapy (OAC plus a single antiplatelet: aspirin or clopi dogrel) before admission. Triple antithrombotic therapy (OAC, aspirin, and clopidogrel) was ad ministered in 1 patient; single VKA, in 3 patients; single aspirin, in 1 patient; single clopidogrel, in 1 patient; and dual antiplatelet treatment (aspi rin and clopidogrel), in 2 patients. Only 1 patient was on NOAC (rivaroxaban) and 1 patient was not treated with any OAC or antiplatelet agent.
The mean (SD) CHA 2 DS 2 VASc score was 3.0 (1.7); 83 patients (60%) had a CHA 2 DS 2 VASc score exceeding 2. The clinical characteristics of the study group are shown in tAbLE 1. reasons for hospital admission and echocardiographic image of the left atrium More than half of the pa tients admitted with ACS (62%) and HF (52%) had SEC, and 30% of the patients with ACS had LAA thrombus. The LAA thrombus was twice as common in patients admitted urgently (13 of 91 patients) as in patients admitted electively (3 of 48 patients) (tAbLE 2). Among patients admitted within up to 48 hours since the onset of arrhyth mia, LAA thrombus was observed in 2 patients (1%) and SEC-in 4 patients (3%).
Predictors of thrombus and spontaneous echo contrast on transesophageal echocardiography A com parison of patients with LAA thrombus and SEC with those without any LA abnormalities on TEE is presented in tAbLEs 3 and 4. Only a history of myocardial infarction was significantly more fre quent in patients with an LAA thrombus com pared with those without thrombus. HF, a high er New York Heart Association class reduced LVEF, and enlarged LA were significantly more common in patients with LA SEC and enlarged LA were significantly more common in patients with LA SEC compared with those without any LA abnormalities.
of admission, duration of arrhythmia, a type of anticoagulant used, and the presence of throm bus in the LAA or the SEC, the χ 2 test was used. To evaluate the prediction of thrombi and SEC on the basis of the CHA 2 DS 2 VASc score, the receiv er operating characteristic curve (ROC) analysis was used. A P value of less than 0.05 was consid ered statistically significant. In
often in patients with a history of HF (OR, 2.23; 95% CI, 1.1-4.53, P = 0.02) and over 3 fold more often in the case of LVEF lower than 40% (OR, 3.65; 95% CI, 1.6-8.06; P = 0.001). Further more, the LA diameter exceeding 45 mm was diag nosed 4 fold more often in patients with SEC (OR, 4.03; 95% CI, 1.91-8.51; P <0.001). In the mul tivariate analysis, the best predictor of SEC in the LA was the LA diameter exceeding 45 mm (OR, 3.08; 95% CI, 1.3-7.29). Both the ejection fraction of less than 40% and a history of HF ap peared to be nonsignificant predictors (OR, 1.86; 95% CI, 0.63-5.4 for LVEF <40% and OR, 0.54; 95% CI, 0.51-3.59 for HF).
The presence of the LAA thrombus was not associated with the mode of hospital admission (elective vs urgent; P = 0.16), duration of arrhyth mia (≤48 hours, >48 hours, >30 days; n = 127; P = 0.56), or the type of anticoagulation (VKA, NOAC, no OAC; P = 0.82). There were no corre lations between LA SEC and the mode of admis sion (P = 0.65), duration of arrhythmia (P = 0.99), or type of anticoagulation (P = 0.57).
chA 2 ds 2 -vAsc score and the presence of spontaneous echo contrast and left atrial appendage thrombus There were no correlations between the CHA 2 DS 2 VASc score and the presence of thrombus in the LAA (P = 0.08) or the CHA 2 DS 2 VASc score and SEC in the LA (P = 0.53). LAA thrombus was diagnosed in patients with at least 1 thromboembolic risk factor (CHA 2 DS 2 VASc ≥1), and LA SEC was found in 1 man with a CHA 2 DS 2 VASc of 0 (FIGurE 1). Patients with a CHA 2 DS 2 VASc of 1 and LAA thrombus were men admit ted urgently due to poor tolerance of arrhythmia, with hypertension (the first patient) and conges tive HF (the second patient). None of them was taking OACs according to the guidelines.
There was no correlation between the mode of admission (elective vs urgent; P = 0.47), the type of anticoagulants taken (VKA, NOAC, no OAC; P = 0.56), the duration of arrhythmia (≤48 h, >48 h, >30 days; P = 0.351), and the CHA 2 DS 2 VASc score.
The CHA 2 DS 2 VASc score proved to be a poor predictor of thrombus or SEC (FIGurE 2A and 2b) . The ROC analysis showed an area under the ROC curve (AUC) of 0.63 (95% CI, 0.55-0.71; P = 0.09) for thrombus and an AUC of 0.53 (95% CI, 0.45-0.62; P = 0.52) for SEC. DCC was performed in 105 patients (76%). It was not performed in 16 patients with LAA thrombus, 8 patients with SEC, 6 patients with sinus restoration directly before DCC, and 3 patients due to an ablation procedure. DCC was ef fective in 93 patients (89% of the performed car dioversions), but in 2 patients, the sinus rhythm was restored after the second DCC (performed <24 hours after the first one). Twelve patients were discharged home with AF/AFl. The mean DCC. The lack of these risk factors can reduce the time of anticoagulation prior to cardiover sion. 20 In our study group, thrombus was re ported in 11.5% of the patients, and simultane ous SEC was reported in 45.3% of the patients (in 15 of 16 patients with thrombus). Based on a meta analysis of more than 20 000 patients who had underwent TEE prior to DCC, throm bus was found in approximately 10% of the pa tients with paroxysmal AF and approximately 15% of those with persistent or chronic arrhyth mia. 8 The prevalence of LAA thrombus, however, may vary considerably among populations. 23, 24 In the available literature, there are scarce data on TEE assessment of the LA in patients admitted urgently due to AF/AFl. In a study by Grewal et al, 6 approximately 53% of the patients were hemodynamically unstable or presented symp toms of arrhythmia, and thrombus was diag nosed in 8.2% of the patients. Most studies in cluded stable patients in whom no anticoagula tion was used prior to TEE or the anticoagula tion was inadequate.
13,20,25-28
cause of admission and the presence of thrombus in the left atrial appendage and spontaneous echo contrast in the left atrium In our study, 65% of the patients were urgently admitted to the hospi tal. The rate of LAA thrombus was 2 fold high er in these patients than in those admitted electively who underwent a TEE exam due to (SD) length of hospitalization was 5.6 (4.6) days (median, 4 days). No complications of TEE or DCC were reported.
dIscussIon AF is associated with a 3.5 to 5 fold higher risk of stroke, 3 fold higher risk of congestive HF, and higher mortality. 8,12 DCC is a recognized method for sinus rhythm resto ration; however, it is associated with a risk for stroke. 17, 18 Thus, treatment with OACs is recom mended prior to DCC.
7, 19 In clinical practice, it is difficult to achieve this goal within 3 weeks in a large group of patients treated with VKAs.
20
According to the ORBIT AF study, 21 only 59% of the INR results were within the therapeutic range. In the case of NOACs, the difficulty lies in the fact that there are no tests to assess the reg ularity of use; therefore, it requires good coop eration with the patient and the patient's com pliance with the physicians recommendations. Based on the results of the RE LY study, 22 about one fifth of the patients stopped taking dabig atran after 2 years, even though they had indi cations for follow up treatment due to risk fac tors for stroke. On the other hand, in patients with no throm botic risk factors (CHA 2 DS 2 VASc = 0; 9 patients) 1 patient was diagnosed with SEC. LAA throm bus was also found in 2 male patients (12.5% of all thrombi) with a CHA 2 DS 2 VASc score of 1. Pu wanat et al 30 analyzed mainly patients at low risk of stroke (80% of patients presented a CHA 2 DS 2 of 1 or lower) admitted for AF ablation. SEC and thrombus in the LA were reported in 0.6% and 1.6% of the patients, respectively (of a total of 1058 patients). No thrombi in the LAA were found in patients with a CHA 2 DS 2 score of 0. 30 In a study by Rader et al 31 analyzing a group of patients admitted for DCC, thrombi in the LAA were found in 3% and SEC in 24% of the patients with a CHA 2 DS 2 score of 0. In this study, in pa tients with a CHA 2 DS 2 score of 2 or higher, throm bi were observed in 13% and SEC in at least 44% of the patients. 31 In a multivariate analysis, Wysokiński et al 34 found that the CHADS 2 score was a predictor of thrombus in the LAA.
34 However, when analyz ing individual components, only some parame ters of this scale (HF, history of stroke/TIA, dia betes), as well as chronic AF, duration of arrhyth mia, and the presence of SEC were found to be in dependent risk factors for thrombus. This mod el was characterized by high diagnostic power (AUC, 0.90). The above results confirm the valid ity of recommendations for DCC and a mandato ry 3 week preparation period or the need to per form TEE before cardioversion. The current Euro pean Society of Cardiology guidelines clarify how to proceed with patients at a low risk of thrombo embolic complications. Only the CHA 2 DS 2 VASc score (not CHA 2 DS 2 ) is recommended for assess ing the risk of stroke in patients with nonvalvu lar AF. OAC is recommended for all men with a CHA 2 DS 2 VASc score of 2 or higher and for all women with a score of 3 or higher. In the case of men with a CHA 2 DS 2 VASc score of 1 or women with a CHA 2 DS 2 VASc of 2, OAC should be con sidered depending on the individual character istics of the patient and his or her preferences.
7
Limitations Our study has a number of limita tions. First, we did not use any specific tests to ver ify patient's compliance, test cognitive function, or monitor drug administration. It was a retrospec tive study and we did not have detailed data on the long term history of the first and recurrent epi sodes of AF. We decided not to include these factors inadequate anticoagulation (13% and 6%, respec tively). Grewal et al 6 reported that thrombus was more common in patients with poor tolerance of arrhythmia (14%) or with symptoms of HF or ACS (10.5%) compared with scheduled patients (7%). 6 The presence of thrombus was also report ed in 12% of hemodynamically stable patients in the ACUTE study.
20
Patients with arrhythmia lasting up to 48 hours Our results suggest that the duration of arrhythmia was not associated with an increased risk of LAA thrombus or SEC in the LA. However, TEE was performed in 9 patients with arrhythmia termi nating within 48 hours. Two of these patients had thrombus in the LAA. In a study of Kleeman et al, 29 thrombus was found in 1.4% of the pa tients and SEC in 35% of hemodynamically sta ble patients with arrhythmia lasting no more than 48 hours. However, thrombus was found in only 4% of patients who had never been treated with OACs prior to admission (37% of the study group). 29 These results suggest that each patient should be treated individually, and despite a rela tively short duration of arrhythmia (≤48 hours), the implemented procedures should depend on the clinical situation and the patient's condition.
Factors affecting the occurrence of thrombus in the left atrial appendage and spontaneous echo contrast in the left atrium In our study, patients with thrombus in the LAA more frequently suffered from diabetes, stroke, or TIA. These patients were older, had symptoms of HF, were in a high er NYHA class, and presented a higher CHA 2 DS 2 VASc score. Interestingly, 7 of 16 patients with an LAA thrombus were on at least dual antithrom botic therapy (VKA plus aspirin or clopodigrel). It is probably due to the fact that 62% of the pa tients with LAA thrombus had myocardial infarc tion in the past. Moreover, they had lower LVEF and an enlarged LA on TTE. However, the only predictor of LAA thrombus was a history of myo cardial infarction. The predictors of SEC includ ed a previously diagnosed HF, LVEF of less than 40%, and an enlarged LA.
A reduced LVEF of less than 35% or less than 40% and an LA diameter enlarged to 45 mm or more were more frequently reported in patients with LAA thrombus and SEC.
29-32 Moderate or se vere LV dysfunction is known to be an indepen dent predictor of stroke 10 ; moreover, HF and low LVEF are negative predictors of LA thrombus res olution in patients with nonvalvular AF.
33 Provi dencia et al 25 reported that the independent pre dictors of LAA thrombus in 180 patients were pos itive troponin levels and enlarged LA (indexed left atrial volume >60.0 ml/m 2 ). 25 In other stud ies, thrombus predictors included older age, fe male sex, hypertension, diabetes, chronic HF, and higher CHA 2 DS 2 and CHA 2 DS 2 VASc scores asso ciated with these factors. 8,34
